Navigating Uterine Cancer: What Every Woman Should Know

With the advent of new, advanced testing techniques, researchers have discovered 4 distinct molecular subtypes of endometrial cancer. These subtypes are now being routinely used in clinical practice and help identify patients at high risk of recurrence and guide treatment options. One of these subtypes shows a high-grade, aggressive tumor phenotype, but has an excellent prognosis and oncologists are not recommending any further treatment besides surgery for these patients. Read this post to learn what molecular subtype you fall into and what natural supplements and treatments can help.

The complete blood count is a test you will be getting frequently as a cancer patient. It is a very detailed analysis of your blood. With this simple test you can learn a lot about what is going on with your health and what cancer treatments are doing to your body. I also share a simple ratio you can calculate from your CBC that has significant implications when it comes to cancer.

In this post and others to come, I will be telling you about important blood tests you should be monitoring. Many of these tests will not be ordered by your doctors so you may have to request them. It’s so important to be proactive when it comes to your health in today’s medical world! The “trifecta” can give you a more comprehensive picture of what is going on in your body and help you know if your treatments are working.

Did you know that endometrial cancer has the highest molecular complexity among common tumor types? Or that it also has the highest number of cancer driver genes? Scientists are making big strides into the complicated world of tumor genetics. This is so important when it comes to your treatments. Read this post to learn more and talk to your oncologist to see if you are on the right path.

Immunotherapy is being used more often for uterine cancer with good success. However, there are some factors that make it more successful for certain patients. Read this post to see if this may be an option for you and talk to your oncologist about it.